H. Ahrendt

发表

Advantages and challenges of oestrogen-free hormonal contraception

Daniela Adolf, K. Buhling, H. Ahrendt, 2010, Current medical research and opinion.

Contraceptive counselling and factors affecting women's contraceptive choices: results of the CHOICE study in Austria.

C. Grimm, J. Bitzer, C. Egarter, 2012, Reproductive biomedicine online.

The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea

U. Karck, H. Ahrendt, T. Pichl, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability.

D. Archer, D. Drouin, H. Ahrendt, 2015, Contraception.

Original research article Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability ☆,☆☆

D. Archer, D. Drouin, H. Ahrendt, 2015 .

Long-term medical management of uterine ﬁ broids with ulipristal acetate

Herv, D. Barlow, J. Donnez, 2022 .

Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial.

H. Teede, K. Gemzell‐Danielsson, D. Mansour, 2010, Contraception.

Prevalence of uterine myomas in women in Germany: data of an epidemiological study

T. Rabe, D. Foth, F. Roehl, 2016, Archives of Gynecology and Obstetrics.

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

I. Milsom, J. Bitzer, I. Nisand, 2006, Contraception.

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.

U. Mellinger, D. Mansour, S. Parke, 2009, Contraception.

Contraception in perimeno- pausal women

G. Göretzlehner, H. Ahrendt, 2016 .

Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)

J. Restrepo, J. Bitzer, D. Trummer, 2015, International journal of women's health.

[Postcoital contraception with dienogest].

I. Amon, G. Köhler, H. Ahrendt, 1987, Zentralblatt für Gynäkologie.

Long-term medical management of uterine fibroids with ulipristal acetate.

D. Barlow, B. Fauser, H. Fernandez, 2016, Fertility and sterility.

Symptoms of uterine myomas: data of an epidemiological study in Germany

T. Rabe, F. Röhl, D. Foth, 2017, Archives of Gynecology and Obstetrics.

Original research article Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 l go f ethinyl estradiol and 3 mg of drospirenone

I. Milsom, J. Bitzer, I. Nisand, 2006 .